Form D · Other Technology

Start9 Labs, Inc.

Denver, CO · CIK 0001845879

Offering snapshot reported Apr 15, 2022 · SEC filing

Reported sold: $7.69M
Investors reported: 23
Minimum accepted: $25K
First sale: Mar 31, 2022

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Apr 15, 2022	Amendment	$7,694,135	$0vs Apr 14, 2022	23	SEC filing
Apr 14, 2022	Initial	$7,694,135	No comparison	23	SEC filing
Feb 11, 2021	Initial	$1,170,000	No comparison	13	SEC filing

Offering details

Securities: Equity
Exemptions: 06c
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-441813

The amount sold includes $3,025,005.46 through issuance of stock for cash under Rule 506(c) and $4,669,129.54 through issuance of stock upon the conversion of outstanding convertible instruments issued under Rule 506(b).

Source: Form D, filed Apr 15, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Aaron Greenspan	Director
Matt Hill	Director, Executive
Keagan Mc Clelland	Director, Executive
Aiden Mc Clelland	Director

Issuer details

Industry: Other Technology (See others in industry)

Address:

3457 Ringsby Ct. #100 B
Denver, CO, 80216